Topics
Oligodendroglioma | Overall management | Overview
Home > Publications > Topics > Oligodendroglioma > Overall management > Overview
Sasaki H, Kitamura Y, Toda M, Hirose Y, Yoshida
K.
Oligodendroglioma, IDH-mutant and
1p/19q-codeleted-prognostic factors, standard of care and
chemotherapy, and future perspectives with neoadjuvant
strategy.
Brain
Tumor Pathol. 2024 Apr 2. doi:
10.1007/s10014-024-00480-1. PMID:
38564040. Review˰ ˍ